ArticleCancer treatment and research communications2020

A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study.

Vinicius Ernani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.